189 related articles for article (PubMed ID: 15474609)
1. The neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine on serotonin, dopamine, and GABA-ergic terminals: an in-vitro autoradiographic study in rats.
Armstrong BD; Noguchi KK
Neurotoxicology; 2004 Dec; 25(6):905-14. PubMed ID: 15474609
[TBL] [Abstract][Full Text] [Related]
2. Differential response of nNOS knockout mice to MDMA ("ecstasy")- and methamphetamine-induced psychomotor sensitization and neurotoxicity.
Itzhak Y; Anderson KL; Ali SF
Ann N Y Acad Sci; 2004 Oct; 1025():119-28. PubMed ID: 15542708
[TBL] [Abstract][Full Text] [Related]
3. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine.
Taraska T; Finnegan KT
J Pharmacol Exp Ther; 1997 Feb; 280(2):941-7. PubMed ID: 9023310
[TBL] [Abstract][Full Text] [Related]
5. Involvement of nicotinic receptors in methamphetamine- and MDMA-induced neurotoxicity: pharmacological implications.
Escubedo E; Camarasa J; Chipana C; García-Ratés S; Pubill D
Int Rev Neurobiol; 2009; 88():121-66. PubMed ID: 19897077
[TBL] [Abstract][Full Text] [Related]
6. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS
Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443
[TBL] [Abstract][Full Text] [Related]
7. 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions.
Bankson MG; Cunningham KA
J Pharmacol Exp Ther; 2001 Jun; 297(3):846-52. PubMed ID: 11356903
[TBL] [Abstract][Full Text] [Related]
8. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
Camarasa J; Pubill D; Escubedo E
Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
[TBL] [Abstract][Full Text] [Related]
9. Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats.
Clemens KJ; Cornish JL; Hunt GE; McGregor IS
Drug Alcohol Depend; 2007 Jan; 86(2-3):183-90. PubMed ID: 16884865
[TBL] [Abstract][Full Text] [Related]
10. Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.
Johnson M; Mitros K; Stone DM; Zobrist R; Hanson GR; Gibb JW
J Pharmacol Exp Ther; 1992 May; 261(2):586-91. PubMed ID: 1374469
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons.
Higuchi M; Suzuki Y; Yatani Y; Kitagawa Y; Nagayasu K; Shirakawa H; Nakagawa T; Kaneko S
J Neurochem; 2008 Sep; 106(6):2410-20. PubMed ID: 18662325
[TBL] [Abstract][Full Text] [Related]
12. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
Clemens KJ; McGregor IS; Hunt GE; Cornish JL
Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831
[TBL] [Abstract][Full Text] [Related]
13. Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release.
Bankson MG; Yamamoto BK
J Neurochem; 2004 Nov; 91(4):852-9. PubMed ID: 15525339
[TBL] [Abstract][Full Text] [Related]
14. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.
Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
Ann N Y Acad Sci; 2004 Oct; 1025():189-97. PubMed ID: 15542717
[TBL] [Abstract][Full Text] [Related]
15. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
[TBL] [Abstract][Full Text] [Related]
16. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine.
Cass WA; Smith MP; Peters LE
Ann N Y Acad Sci; 2006 Aug; 1074():261-71. PubMed ID: 17105922
[TBL] [Abstract][Full Text] [Related]
17. Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain.
Kaewsuk S; Sae-ung K; Phansuwan-Pujito P; Govitrapong P
Neurochem Int; 2009 Nov; 55(6):397-405. PubMed ID: 19409439
[TBL] [Abstract][Full Text] [Related]
18. The effects of p-chloroamphetamine, methamphetamine and 3,4-methylenedioxymethamphetamine (ecstasy) on the gene expression of cytoskeletal proteins in the rat brain.
Putzke J; Spina MG; Büchler J; Kovar KA; Wolf G; Smalla KH
Addict Biol; 2007 Mar; 12(1):69-80. PubMed ID: 17407499
[TBL] [Abstract][Full Text] [Related]
19. Methamphetamine and 3,4-methylenedioxymethamphetamine interact with central nicotinic receptors and induce their up-regulation.
Garcia-Ratés S; Camarasa J; Escubedo E; Pubill D
Toxicol Appl Pharmacol; 2007 Sep; 223(3):195-205. PubMed ID: 17614110
[TBL] [Abstract][Full Text] [Related]
20. Quantitative mapping shows that serotonin rather than dopamine receptor mRNA expressions are affected after repeated intermittent administration of MDMA in rat brain.
Kindlundh-Högberg AM; Svenningsson P; Schiöth HB
Neuropharmacology; 2006 Sep; 51(4):838-47. PubMed ID: 16820177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
